These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25936721)

  • 61. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
    Minchella A; Molinari L; Alonso S; Bouziges N; Sotto A; Lavigne JP
    Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Current therapies for pseudomonas aeruginosa.
    Giamarellou H; Kanellakopoulou K
    Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A control study on bacterial resistance and clinical features of lower respiratory tract infection with Pseudomonas aeruginosa in medical intensive care unit and general ward].
    Shao C; Qu J; He L; Ni C; Hu B
    Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):813-7. PubMed ID: 12654234
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
    Al-Jasser AM; Elkhizzi NA
    Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Pseudomonas aeruginosa: antimicrobial resistance in clinical isolates. Castellón 2004-2008].
    Pardo Serrano FJ; Tirado Balaguer MD; García Zúñiga ED; Granados Ortega J; Campos Aznar A; Moreno Muñoz R
    Rev Esp Quimioter; 2010 Mar; 23(1):20-6. PubMed ID: 20232020
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV; Gel'fand EB; Mamontova OA
    Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.
    Lewis GJ; Fang X; Gooch M; Cook PP
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):368-73. PubMed ID: 22418632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome.
    Nguyen LH; Hsu DI; Ganapathy V; Shriner K; Wong-Beringer A
    J Antimicrob Chemother; 2008 Mar; 61(3):714-20. PubMed ID: 18222951
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use.
    Muder RR; Brennen C; Drenning SD; Stout JE; Wagener MM
    Infect Control Hosp Epidemiol; 1997 Dec; 18(12):809-13. PubMed ID: 9442404
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.
    Micek ST; Wunderink RG; Kollef MH; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Torres A; Menichetti F; Schramm GE; Menon V
    Crit Care; 2015 May; 19(1):219. PubMed ID: 25944081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity.
    Paramythiotou E; Lucet JC; Timsit JF; Vanjak D; Paugam-Burtz C; Trouillet JL; Belloc S; Kassis N; Karabinis A; Andremont A
    Clin Infect Dis; 2004 Mar; 38(5):670-7. PubMed ID: 14986251
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
    Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effects of antibiotic cycling and mixing on acquisition of antibiotic resistant bacteria in the ICU: A post-hoc individual patient analysis of a prospective cluster-randomized crossover study.
    van Duijn PJ; Verbrugghe W; Jorens PG; Spöhr F; Schedler D; Deja M; Rothbart A; Annane D; Lawrence C; Jereb M; Seme K; Šifrer F; Tomič V; Estevez F; Carneiro J; Harbarth S; Bonten MJM
    PLoS One; 2022; 17(5):e0265720. PubMed ID: 35503768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk factors for carbapenem-nonsusceptible Pseudomonas aeruginosa: Case-control study.
    Khadem T; Stevens V; Holt K; Hoffmann C; Dumyati G; Brown J
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):146-150. PubMed ID: 28780998
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
    Yüce A; Yapar N; Eren Kutsoylu O
    Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates.
    Lodise TP; Miller C; Patel N; Graves J; McNutt LA
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):959-65. PubMed ID: 17620244
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.